BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31302073)

  • 1. Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome.
    Matsui Y; Hiraki T; Gobara H; Iguchi T; Tomita K; Uka M; Araki M; Nasu Y; Furuya M; Kanazawa S
    Diagn Interv Imaging; 2019 Nov; 100(11):671-677. PubMed ID: 31302073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt-Hogg-Dubé Syndrome.
    Bodard S; Boudhabhay I; Dariane C; Delavaud C; Guinebert S; Joly D; Timsit MO; Mejean A; Verkarre V; Hélénon O; Richard S; Correas JM
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dubé Syndrome].
    Tohi Y; Makita N; Suzuki I; Suzuki R; Fukunaga A; Kubota M; Matsuoka T; Sugino Y; Inoue K; Uehara K; Imai Y; Kawakita M
    Hinyokika Kiyo; 2018 Mar; 64(3):107-110. PubMed ID: 29684959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
    Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
    J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 14. Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum.
    Furuya M; Hasumi H; Yao M; Nagashima Y
    Cancer Sci; 2020 Jan; 111(1):15-22. PubMed ID: 31777168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial comment to Case of bilateral and multifocal renal cell carcinoma associated with Birt-Hogg-Dubé syndrome.
    Kuroda N
    Int J Urol; 2015 Feb; 22(2):231-2. PubMed ID: 25358756
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal imaging in 199 Dutch patients with Birt-Hogg-Dubé syndrome: Screening compliance and outcome.
    Johannesma PC; van de Beek I; van der Wel TJWT; Reinhard R; Rozendaal L; Starink TM; van Waesberghe JHTM; Horenblas S; Gille HJJP; Jonker MA; Meijers-Heijboer HEJ; Postmus PE; Houweling AC; van Moorselaar JRA
    PLoS One; 2019; 14(3):e0212952. PubMed ID: 30845233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome.
    Zbar B; Alvord WG; Glenn G; Turner M; Pavlovich CP; Schmidt L; Walther M; Choyke P; Weirich G; Hewitt SM; Duray P; Gabril F; Greenberg C; Merino MJ; Toro J; Linehan WM
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):393-400. PubMed ID: 11927500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.